6533b838fe1ef96bd12a5120
RESEARCH PRODUCT
Oxidative stress modulates rearrangement of endoplasmic reticulum-mitochondria contacts and calcium dysregulation in a Friedreich's ataxia model
Tamara Lapeña-luzónPablo Calap-quintanaFederico V. PallardóJuan A. NavarroStephan SchneuwlyPilar Gonzalez-caboLaura R. Rodríguezsubject
0301 basic medicineAtaxiaClinical BiochemistryLipid peroxidationchemistry.chemical_elementMitochondrionCalciumEndoplasmic ReticulumBiochemistry03 medical and health sciences0302 clinical medicineMAMsmedicineAnimalsVitamin EMitochondrial calcium uptakelcsh:QH301-705.5Calcium signalinglcsh:R5-920biologyFrataxinEndoplasmic reticulumOrganic ChemistryN-acetylcysteineMitochondriaCell biologyOxidative StressDrosophila melanogaster030104 developmental biologychemistrylcsh:Biology (General)Friedreich AtaxiaFrataxinbiology.proteinCalciummedicine.symptomCellular modellcsh:Medicine (General)030217 neurology & neurosurgeryResearch Paperdescription
Friedreich ataxia (FRDA) is a neurodegenerative disorder characterized by neuromuscular and neurological manifestations. It is caused by mutations in the FXN gene, which results in loss of the mitochondrial protein frataxin. Endoplasmic Reticulum-mitochondria associated membranes (MAMs) are inter-organelle structures involved in the regulation of essential cellular processes, including lipid metabolism and calcium signaling. In the present study, we have analyzed in both, unicellular and multicellular models of FRDA, calcium management and integrity of MAMs. We observed that function of MAMs is compromised in our cellular model of FRDA, which was improved upon treatment with antioxidants. In agreement, promoting mitochondrial calcium uptake was sufficient to restore several defects caused by frataxin deficiency in Drosophila Melanogaster. Remarkably, our findings describe for the first time frataxin as a member of the protein network of MAMs, where interacts with two of the main proteins implicated in endoplasmic reticulum-mitochondria communication. These results suggest a new role of frataxin, indicate that FRDA goes beyond mitochondrial defects and highlight MAMs as novel therapeutic candidates to improve patient's conditions.
year | journal | country | edition | language |
---|---|---|---|---|
2020-10-01 | Redox Biology |